Coherus Biosciences Inc  

(Public, NASDAQ:CHRS)   Watch this stock  
Find more results for CHRS
28.41
+1.44 (5.34%)
Mar 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 26.08 - 28.47
52 week 12.27 - 33.30
Open 27.13
Vol / Avg. 0.00/169,122.00
Mkt cap 946.75M
P/E     -
Div/yield     -
EPS -2.26
Shares 33.32M
Beta     -
Inst. own 47%
Mar 23, 2015
Q4 2014 Coherus BioSciences Inc Earnings Call - Webcast
Mar 23, 2015
Q4 2014 Coherus BioSciences Inc Earnings Release
Mar 2, 2015
Coherus Biosciences Inc at Cowen Health Care Conference - Webcast
Feb 11, 2015
Coherus Biosciences Inc at Leerink Global Healthcare Conference
Jan 12, 2015
Coherus Biosciences Inc at JPMorgan Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -49.30% -1949.65%
Operating margin -40.01% -1308.36%
EBITD margin - -1293.67%
Return on average assets -25.26% -145.00%
Return on average equity - -
Employees 57 -
CDP Score - -

Address

201 Redwood Shores Pkwy Ste 200
REDWOOD CITY, CA 94065-1181
United States - Map
+1-650-6493530 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Coherus BioSciences Inc. (Coherus) is a late-stage clinical biologics platform Company. The Company is focused on delivering biosimilar therapeutics. Biosimilars are intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases. The Company has worked on approximately 100 molecules, developed and manufactured around 14 products and launched approximately 30 products across the world. Coherus� is in partnerships include global pharmaceutical companies in Europe, Asia and Latin America.

Officers and directors

Dennis M. Lanfear Chairman of the Board, President, Chief Executive Officer
Age: 59
Bio & Compensation  - Reuters
Jean-Frederic Viret Ph.D. Chief Financial Officer
Age: 49
Bio & Compensation  - Reuters
Peter K. Watler Chief Technology Officer
Age: 53
Bio & Compensation  - Reuters
Alan C. Herman Ph.D. Chief Scientific Officer
Age: 67
Bio & Compensation  - Reuters
Barbara K. Finck M.D. Chief Medical Officer
Age: 67
Bio & Compensation  - Reuters
Christos Richards Director
Age: 57
Bio & Compensation  - Reuters
August J. Troendle M.D. Director
Age: 58
Bio & Compensation  - Reuters
James I. Healy M.D., Ph.D. Independent Director
Age: 49
Bio & Compensation  - Reuters
V. Bryan Lawlis Jr., Ph.D. Independent Director
Age: 63
Bio & Compensation  - Reuters
Ali J. Satvat Independent Director
Age: 37
Bio & Compensation  - Reuters